Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:26:39.969Z.
Calculation as of: 2026-10-06T13:26:39.969Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1c66db039e427230ae26789b54a30ba38da86a4a62527efc47f68a44edb52430
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-17.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Monte Rosa Therapeutics, Inc.
Market Cap
$867.60M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$903.13M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$819.44M
EV/EBIT Ratio
N/A
TTM Avg
103.45x
3Y Avg
72.64x
5Y Avg
72.64x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | $867.60M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $856.30M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $844.28M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | N/A | 9.35x | 9.35x | 9.35x |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | N/A | 103.45x | 72.64x | 72.64x |
| Bioventus Inc. (BVS)vs › | $915.95M | 18.60x | 17.93x | 24.19x | 30.14x |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 34.44x | 30.80x | 40.41x | 53.37x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-03-17 | 96.62x |
| 2026-03-16 | 98.94x |
| 2026-03-13 | 96.55x |
| 2026-03-12 | 96.69x |
| 2026-03-11 | 104.10x |
| 2026-03-10 | 105.69x |
| 2026-03-09 | 108.45x |
| 2026-03-06 | 109.47x |
| 2026-03-05 | 110.56x |
| 2026-03-04 | 115.35x |
| 2026-03-03 | 110.63x |
| 2026-03-02 | 114.55x |
| 2026-02-27 | 109.11x |
| 2026-02-26 | 114.55x |
| 2026-02-25 | 111.57x |
| 2026-02-24 | 119.71x |
| 2026-02-23 | 121.88x |
| 2026-02-20 | 118.04x |
| 2026-02-19 | 119.34x |
| 2026-02-18 | 112.95x |
| 2026-02-17 | 113.53x |
| 2026-02-13 | 110.34x |
| 2026-02-12 | 114.55x |
| 2026-02-11 | 117.89x |
| 2026-02-10 | 122.32x |
| 2026-02-09 | 122.46x |
| 2026-02-06 | 122.17x |
| 2026-02-05 | 117.46x |
| 2026-02-04 | 122.03x |
| 2026-02-03 | 132.19x |
| 2026-02-02 | 131.83x |
| 2026-01-30 | 129.22x |
| 2026-01-29 | 135.31x |
| 2026-01-28 | 133.65x |
| 2026-01-27 | 147.95x |
| 2026-01-26 | 142.79x |
| 2026-01-23 | 146.06x |
| 2026-01-22 | 147.37x |
| 2026-01-21 | 156.15x |
| 2026-01-20 | 157.68x |
| 2026-01-16 | 152.38x |
| 2026-01-15 | 155.06x |
| 2026-01-14 | 154.92x |
| 2026-01-13 | 154.41x |
| 2026-01-12 | 152.45x |
| 2026-01-09 | 156.51x |
| 2026-01-08 | 163.99x |
| 2026-01-07 | 149.25x |
| 2026-01-06 | 96.47x |
| 2026-01-05 | 84.78x |
| 2026-01-02 | 91.39x |
| 2025-12-31 | 94.08x |
| 2025-12-30 | 96.18x |
| 2025-12-29 | 97.27x |
| 2025-12-26 | 105.77x |
| 2025-12-24 | 108.31x |
| 2025-12-23 | 99.89x |
| 2025-12-22 | 97.78x |
| 2025-12-19 | 93.06x |
| 2025-12-18 | 95.17x |
| 2025-12-17 | 101.85x |
| 2025-12-16 | 115.71x |
| 2025-12-15 | 99.67x |
| 2025-12-12 | 98.65x |
| 2025-12-11 | 100.47x |
| 2025-12-10 | 105.33x |
| 2025-12-09 | 103.59x |
| 2025-12-08 | 109.83x |
| 2025-12-05 | 106.64x |
| 2025-12-04 | 105.55x |
| 2025-12-03 | 102.64x |
| 2025-12-02 | 92.12x |
| 2025-12-01 | 94.80x |
| 2025-11-28 | 97.64x |
| 2025-11-26 | 96.33x |
| 2025-11-25 | 96.55x |
| 2025-11-24 | 94.66x |
| 2025-11-21 | 83.48x |
| 2025-11-20 | 78.40x |
| 2025-11-19 | 82.90x |
| 2025-11-18 | 80.28x |
| 2025-11-17 | 79.05x |
| 2025-11-14 | 84.49x |
| 2025-11-13 | 84.20x |
| 2025-11-12 | 83.04x |
| 2025-11-11 | 84.20x |
| 2025-11-10 | 82.32x |
| 2025-11-07 | 69.61x |
| 2025-11-06 | 51.78x |
| 2025-11-05 | 48.90x |
| 2025-11-04 | 47.62x |
| 2025-11-03 | 47.91x |
| 2025-10-31 | 51.12x |
| 2025-10-30 | 51.78x |
| 2025-10-29 | 49.68x |
| 2025-10-28 | 49.39x |
| 2025-10-27 | 48.94x |
| 2025-10-24 | 44.07x |
| 2025-10-23 | 40.93x |
| 2025-10-22 | 36.68x |
| 2025-10-21 | 37.67x |
| 2025-10-20 | 38.83x |
| 2025-10-17 | 39.57x |
| 2025-10-16 | 40.64x |
| 2025-10-15 | 43.95x |
| 2025-10-14 | 41.88x |
| 2025-10-13 | 41.02x |
| 2025-10-10 | 39.53x |
| 2025-10-09 | 33.01x |
| 2025-10-08 | 29.92x |
| 2025-10-07 | 28.56x |
| 2025-10-06 | 29.71x |
| 2025-10-03 | 30.04x |
| 2025-10-02 | 29.59x |
| 2025-10-01 | 29.05x |
| 2025-09-30 | 28.68x |
| 2025-09-29 | 28.27x |
| 2025-09-26 | 29.01x |
| 2025-09-25 | 25.13x |
| 2025-09-24 | 25.42x |
| 2025-09-23 | 24.22x |
| 2025-09-22 | 25.05x |
| 2025-09-19 | 24.22x |
| 2025-09-18 | 26.70x |
| 2025-09-17 | 24.35x |
| 2025-09-16 | 24.80x |
| 2025-09-15 | 26.70x |
| 2025-09-12 | 17.95x |
| 2025-09-11 | 18.28x |
| 2025-09-10 | 17.91x |
| 2025-09-09 | 18.04x |
| 2025-09-08 | 17.91x |
| 2025-09-05 | 18.49x |
| 2025-09-04 | 18.37x |
| 2025-09-03 | 18.74x |
| 2025-09-02 | 18.41x |
| 2025-08-29 | 17.91x |
| 2025-08-28 | 18.04x |
| 2025-08-27 | 17.38x |
| 2025-08-26 | 17.38x |
| 2025-08-25 | 17.05x |
| 2025-08-22 | 17.99x |
| 2025-08-21 | 16.67x |
| 2025-08-20 | 16.39x |
| 2025-08-19 | 16.26x |
| 2025-08-18 | 16.92x |
| 2025-08-15 | 17.00x |
| 2025-08-14 | 16.06x |
| 2025-08-13 | 16.43x |
| 2025-08-12 | 16.47x |
| 2025-08-11 | 15.40x |
| 2025-08-08 | 16.18x |
